Trials / Active Not Recruiting
Active Not RecruitingNCT04001205
Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study
Effect of Atrial Fibrillation Burden on Long-term Risk of Thromboembolic Complications- the FinCV-4 Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,300 (estimated)
- Sponsor
- University of Turku · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study explores the association of symptomatic episodes of atrial fibrillation (AF) occurrence and long-term risk of thromboembolic complications in a retrospective setting.
Detailed description
The study population consists of the FinCV-dataset, which includes 7660 acute cardioversions for atrial fibrillation. The electronic patient records of FinCV-study patients are reviewed to collect data on anticoagulation, number of cardioversions as well as mortality and stroke data. We seek to explore the possible association between the frequency of AF paroxysms in low stroke risk patients and the occurrence of death, stroke and major bleed as well as the net clinical benefit of anticoagulation. Data collection is performed by reviewing electronic patient records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anticoagulation Therapy | Long term oral anticoagulation with VKA (vitamin K antagonist) or NOAC (non-vitamin K oral anticoagulant) |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2025-01-08
- Completion
- 2025-01-08
- First posted
- 2019-06-27
- Last updated
- 2024-05-08
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT04001205. Inclusion in this directory is not an endorsement.